4-aminobenzoic acid has been researched along with Metabolic Syndrome in 1 studies
para-Aminobenzoates: Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.
4-aminobenzoate : An aromatic amino-acid anion that is the conjugate base of 4-aminobenzoic acid.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An orally bioavailable small molecule inhibitor of plasminogen activator inhibitor‑1 (PAI‑1) is currently being clinically assessed as a novel antithrombotic agent." | 1.56 | Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats. ( Aihara, Y; Asada, K; Douhara, A; Kaji, K; Kawaratani, H; Kitade, M; Miyata, T; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Takaya, H; Yoshiji, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noguchi, R | 1 |
| Kaji, K | 1 |
| Namisaki, T | 1 |
| Moriya, K | 1 |
| Kawaratani, H | 1 |
| Kitade, M | 1 |
| Takaya, H | 1 |
| Aihara, Y | 1 |
| Douhara, A | 1 |
| Asada, K | 1 |
| Nishimura, N | 1 |
| Miyata, T | 1 |
| Yoshiji, H | 1 |
1 other study available for 4-aminobenzoic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
Topics: Administration, Oral; Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fibrinol | 2020 |